Liposomal nanoparticles encapsulating iloprost exhibit enhanced vasodilation in pulmonary arteries
Pritesh P Jain,1 Regina Leber,1,2 Chandran Nagaraj,1 Gerd Leitinger,3 Bernhard Lehofer,4 Horst Olschewski,1,5 Andrea Olschewski,1,6 Ruth Prassl,1,4 Leigh M Marsh11Ludwig Boltzmann Institute for Lung Vascular Research, 2Biophysics Division, Institute of Molecular Biosciences, University of Graz, 3Re...
Guardado en:
Autores principales: | Jain PP, Leber R, Nagaraj C, Leitinger G, Lehofer B, Olschewski H, Olschewski A, Prassl R, Marsh LM |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6dbf530d43774c399bd3f5e19398ee19 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Revisiting the Large-Conductance Calcium-Activated Potassium (BKCa) Channels in the Pulmonary Circulation
por: Divya Guntur, et al.
Publicado: (2021) -
The definition of pulmonary hypertension: history, practical implications and current controversies
por: Gabor Kovacs, et al.
Publicado: (2021) -
Hyperbaric Oxygen Therapy with Iloprost Improves Digit Salvage in Severe Frostbite Compared to Iloprost Alone
por: Marie-Anne Magnan, et al.
Publicado: (2021) -
PeakPCO combined with FEV1/FVC predicts vasodilator-responsive patients with idiopathic pulmonary arterial hypertension
por: Ci-Jun Luo, et al.
Publicado: (2021) -
Evidence base for specific pulmonary vasodilators in adults with congenital heart disease
por: Anton A. Shmalts, et al.
Publicado: (2021)